- Home
- NXN vs BEAT Comparison
NXN vs BEAT Comparison
Compare NXN & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- BEAT
- Stock Information
- Founded
- NXN 1992
- BEAT 2015
- Country
- NXN United States
- BEAT United States
- Employees
- NXN N/A
- BEAT N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- NXN Finance
- BEAT Technology
- Exchange
- NXN Nasdaq
- BEAT Nasdaq
- Market Cap
- NXN 45.4M
- BEAT 51.1M
- IPO Year
- NXN N/A
- BEAT 2021
- Fundamental
- Price
- NXN $11.50
- BEAT $1.25
- Analyst Decision
- NXN
- BEAT Buy
- Analyst Count
- NXN 0
- BEAT 1
- Target Price
- NXN N/A
- BEAT $8.00
- AVG Volume (30 Days)
- NXN 9.7K
- BEAT 143.9K
- Earning Date
- NXN 01-01-0001
- BEAT 08-13-2025
- Dividend Yield
- NXN 4.23%
- BEAT N/A
- EPS Growth
- NXN N/A
- BEAT N/A
- EPS
- NXN 0.24
- BEAT N/A
- Revenue
- NXN N/A
- BEAT N/A
- Revenue This Year
- NXN N/A
- BEAT N/A
- Revenue Next Year
- NXN N/A
- BEAT N/A
- P/E Ratio
- NXN $48.42
- BEAT N/A
- Revenue Growth
- NXN N/A
- BEAT N/A
- 52 Week Low
- NXN $10.64
- BEAT $1.17
- 52 Week High
- NXN $12.45
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- NXN 46.55
- BEAT 34.77
- Support Level
- NXN $11.49
- BEAT $1.17
- Resistance Level
- NXN $11.61
- BEAT $1.37
- Average True Range (ATR)
- NXN 0.11
- BEAT 0.09
- MACD
- NXN -0.01
- BEAT -0.00
- Stochastic Oscillator
- NXN 2.08
- BEAT 22.86
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.